Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?

May 8, 2026 updated by: Douglas Hutchinson, University of Utah

Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Sensory Feedback Useful for Controlling a Prosthetic Device?

The investigators will investigate the device feasibility of human peripheral nerves and muscles recording and stimulation using percutaneous Utah Slanted Electrode Arrays (pUSEAs) implanted into residual peripheral arm nerves and EMG electrodes implanted in the residual muscles of patients with limb amputations in order to determine the ability of the HAPTIX (Hand Proprioception and Touch Interfaces) System to control an upper-extremity prosthesis, and to provide a sense of cutaneous touch and muscle proprioceptive feedback to the amputee.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The investigators will assess the functional capability of microelectrode slanted arrays with a large number of electrodes implanted into peripheral nerves of patients with upper-limb transradial amputations. The investigators hypothesize that recording neural signals from individual electrodes will provide selective motor information that is adequate to allow control over artificial limbs with many moving parts, i.e., wrist, and individually moving digits. These studies will also investigate to what extent microstimulation can provide sensory feedback from a prosthetic limb.

The HAPTIX System study will investigate the safety and efficacy of using electromyography (EMG), plus neural recording and nerve stimulation, to control and provide cutaneous and proprioceptive feedback from a dexterous, motorized and sensorized, upper-extremity prosthesis (e.g., the DEKA LUKE arm) used by amputees.

The HAPTIX System is intended to permit the function of an upper-extremity prosthesis to assist in activities of daily living (ADLs) using neurostimulation and recording of EMG and neural signals to control the prosthesis, and evoke touch sensation and proprioception in upper-extremity amputees with DEKA LUKE sensorized upper extremity prosthesis.

The HAPTIX System study is an early feasibility study (EFS) of the use of a combination of EMG recording electrodes, neural recording and stimulating electrodes, and external electronics and algorithms designed to provide sensory and proprioceptive feedback to the amputee, and to control movements of a prosthetic hand.

EMG signals from the residual forearm muscles of amputees will be recorded using up to 8 custom bipolar PermaLoc® electrodes. The incorporation of these electrodes into the HAPTIX System is described in 001_G190131A002_Amended_Device Description. Nerve signals will also be recorded using up to 3 percutaneous Utah Slanted Electrode Arrays (pUSEAs), whose electrode tips will be implanted intrafascicularly in residual arm nerves. Present-version pUSEAs utilize a transcutaneous lead and extracorporeal connector. Motor signals from the nerve will contribute to decoding motor intents decoded to control an advanced prosthetic hand. Nerve stimulation to evoke sensory perceptions will be provided by passing current through individual pUSEA electrodes, separately or in combination.

Study Type

Interventional

Enrollment (Estimated)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84108
        • Recruiting
        • The University Orthopaedic Center
        • Contact:
          • Douglas Hutchinson, M.D.
          • Phone Number: 801-587-5453

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • at least 18 years of age and less than 65 years of age
  • unilateral and bilateral traumatic or elective upper extremity amputations at the transradial level

Exclusion Criteria:

  • incarceration
  • pregnancy
  • inability to consent
  • psychiatric comorbidity
  • medical conditions that significantly increase the risk of adverse effects of general anesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Implantation of a percutaneous Utah Slanted Electrode Arrays (pUSEAs)
The arm (s) of the patient which has been amputated. Intervention include insertion of the percutaneous Utah Slanted Electrode Arrays which will interact with nerve endings in order to gain knowledge about device feasibility and nerve stimulation.
Microelectrode slanted arrays with a large number of electrodes will be surgically implanted into peripheral nerves of patients with limb amputations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure Action Potentials (millivolts, mV)
Time Frame: Up to 2-years Follow-up
Three participants after receiving a stimuli will have action potentials (millivolts, mV) arising from the axons surrounding the tip of each electrode recorded in time. The moving action potentials (mV) measure five phases: resting potential, depolarization, peak, repolarization, and hyperpolarization.
Up to 2-years Follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Douglas Hutchinson, M.D., University of Utah Orthopaedics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 21, 2020

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

August 12, 2022

First Submitted That Met QC Criteria

August 15, 2022

First Posted (Actual)

August 17, 2022

Study Record Updates

Last Update Posted (Actual)

May 13, 2026

Last Update Submitted That Met QC Criteria

May 8, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 124231

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on percutaneous Utah Slanted Electrode Arrays (pUSEAs)

Subscribe